Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontranslation termination factor activity

GSPT2 GSPT1

1.44e-047532GO:0008079
GeneOntologyMolecularFunctionintracellularly cGMP-activated cation channel activity

CNGB3 CNGA2

1.44e-047532GO:0005223
GeneOntologyMolecularFunctiontranslation release factor activity

GSPT2 GSPT1

1.44e-047532GO:0003747
GeneOntologyMolecularFunctionintracellularly cAMP-activated cation channel activity

CNGB3 CNGA2

3.07e-0410532GO:0005222
GeneOntologyMolecularFunctionintracellularly cyclic nucleotide-activated monoatomic cation channel activity

CNGB3 CNGA2

5.29e-0413532GO:0005221
GeneOntologyMolecularFunctioncyclic nucleotide-activated monoatomic ion channel activity

CNGB3 CNGA2

5.29e-0413532GO:0043855
GeneOntologyMolecularFunctioncGMP binding

CNGB3 CNGA2

8.10e-0416532GO:0030553
GeneOntologyMolecularFunctionguanyl ribonucleotide binding

GUF1 GSPT2 CNGB3 CNGA2 MX1 GSPT1

1.05e-03439536GO:0032561
GeneOntologyMolecularFunctionguanyl nucleotide binding

GUF1 GSPT2 CNGB3 CNGA2 MX1 GSPT1

1.05e-03439536GO:0019001
GeneOntologyMolecularFunctiontranslation factor activity, RNA binding

GSPT2 EIF3D GSPT1

1.50e-0385533GO:0008135
GeneOntologyMolecularFunctiondeath receptor binding

CFLAR MADD

1.99e-0325532GO:0005123
GeneOntologyMolecularFunctiontranslation regulator activity, nucleic acid binding

GSPT2 EIF3D GSPT1

3.28e-03112533GO:0090079
GeneOntologyMolecularFunctionintracellularly ligand-gated monoatomic ion channel activity

CNGB3 CNGA2

3.46e-0333532GO:0005217
GeneOntologyMolecularFunctionribosome binding

SLFN12L GUF1 SLFN12

3.98e-03120533GO:0043022
GeneOntologyMolecularFunctioncyclic nucleotide binding

CNGB3 CNGA2

4.81e-0339532GO:0030551
GeneOntologyCellularComponenttranslation release factor complex

GSPT2 GSPT1

1.89e-053532GO:0018444
GeneOntologyCellularComponentintracellular cyclic nucleotide activated cation channel complex

CNGB3 CNGA2

1.31e-047532GO:0017071
GeneOntologyCellularComponentcytosolic ribosome

RPS4Y1 RPL7A GSPT1 RPL18A

2.76e-04124534GO:0022626
DomainG_TR_CS

GUF1 GSPT2 GSPT1

1.59e-069513IPR031157
DomainG_TR_1

GUF1 GSPT2 GSPT1

5.38e-0613513PS00301
DomainEFTu-like_2

GUF1 GSPT2 GSPT1

1.52e-0518513IPR004161
DomainGTP_EFTU_D2

GUF1 GSPT2 GSPT1

1.52e-0518513PF03144
DomainG_TR_2

GUF1 GSPT2 GSPT1

1.52e-0518513PS51722
DomainTF_GTP-bd_dom

GUF1 GSPT2 GSPT1

1.80e-0519513IPR000795
DomainTransl_B-barrel

GUF1 GSPT2 GSPT1

5.36e-0527513IPR009000
DomainHSR

SP100 SP110

7.27e-055512PS51414
Domain-

CD9 CD81

7.27e-0555121.10.1450.10
DomainHSR

SP100 SP110

7.27e-055512PF03172
DomainCD81_LEL

CD9 CD81

7.27e-055512IPR028977
DomainHSR_dom

SP100 SP110

7.27e-055512IPR004865
DomainCytokine_IL1-like

IL36B FGF8 SORCS1

1.29e-0436513IPR008996
DomainAlbA_2

SLFN12L SLFN12

1.52e-047512PF04326
DomainSchlafen

SLFN12L SLFN12

1.52e-047512IPR029684
DomainSchlafen_AAA_dom

SLFN12L SLFN12

1.52e-047512IPR007421
DomainSAND_dom

SP100 SP110

2.03e-048512IPR000770
DomainTransl_elong_EFTu/EF1A_C

GSPT2 GSPT1

2.03e-048512IPR004160
DomainSAND

SP100 SP110

2.03e-048512PF01342
DomainGTP_EFTU_D3

GSPT2 GSPT1

2.03e-048512PF03143
DomainSAND

SP100 SP110

2.03e-048512PS50864
DomainSAND

SP100 SP110

2.03e-048512SM00258
DomainTransl_elong_EF1A/Init_IF2_C

GSPT2 GSPT1

3.24e-0410512IPR009001
Domain-

SP100 SP110

4.74e-04125123.10.390.10
DomainSAND_dom-like

SP100 SP110

4.74e-0412512IPR010919
DomaincNMP-bd_CS

CNGB3 CNGA2

8.56e-0416512IPR018488
DomainZF_BBOX

TRIM66 MYCBP2 TRIM36

1.36e-0380513PS50119
DomainZnf_B-box

TRIM66 MYCBP2 TRIM36

1.41e-0381513IPR000315
DomainTetraspanin_CS

CD9 CD81

1.49e-0321512IPR018503
DomainTM4_1

CD9 CD81

2.28e-0326512PS00421
DomainIg_E-set

TGM4 MYCBP2 NXPE4

2.88e-03104513IPR014756
DomainCNMP_BINDING_1

CNGB3 CNGA2

3.44e-0332512PS00888
DomainCNMP_BINDING_2

CNGB3 CNGA2

3.44e-0332512PS00889
DomainTetraspanin

CD9 CD81

3.44e-0332512IPR000301
DomainTetraspanin_EC2

CD9 CD81

3.44e-0332512IPR008952
DomainTetraspannin

CD9 CD81

3.66e-0333512PF00335
DomainTetraspanin/Peripherin

CD9 CD81

3.66e-0333512IPR018499
DomainIon_trans_dom

CNGB3 CACNA1I CNGA2

3.73e-03114513IPR005821
DomainIon_trans

CNGB3 CACNA1I CNGA2

3.73e-03114513PF00520
DomaincNMP

CNGB3 CNGA2

3.88e-0334512SM00100
DomaincNMP_binding

CNGB3 CNGA2

3.88e-0334512PF00027
DomaincNMP-bd_dom

CNGB3 CNGA2

4.11e-0335512IPR000595
DomainCNMP_BINDING_3

CNGB3 CNGA2

4.11e-0335512PS50042
DomainBROMODOMAIN_1

TRIM66 SP110

4.58e-0337512PS00633
DomaincNMP-bd-like

CNGB3 CNGA2

4.83e-0338512IPR018490
DomainBROMODOMAIN_2

TRIM66 SP110

5.60e-0341512PS50014
DomainBROMO

TRIM66 SP110

5.87e-0342512SM00297
DomainBromodomain

TRIM66 SP110

5.87e-0342512IPR001487
Domain-

TRIM66 SP110

5.87e-03425121.20.920.10
Domain-

TRIM66 MYCBP2 FGD5 TRIM36 SP110

7.44e-034495153.30.40.10
DomainZnf_FYVE_PHD

TRIM66 FGD5 SP110

7.55e-03147513IPR011011
Domain-

CNGB3 CNGA2

7.61e-03485122.60.120.10
DomainZnf_RING/FYVE/PHD

TRIM66 MYCBP2 FGD5 TRIM36 SP110

8.14e-03459515IPR013083
PathwayREACTOME_NONSENSE_MEDIATED_DECAY_NMD_INDEPENDENT_OF_THE_EXON_JUNCTION_COMPLEX_EJC

GSPT2 RPS4Y1 RPL7A GSPT1 RPL18A

3.14e-0696345MM15705
PathwayREACTOME_NONSENSE_MEDIATED_DECAY_NMD

GSPT2 RPS4Y1 RPL7A GSPT1 RPL18A

7.63e-06115345MM15640
PathwayREACTOME_NONSENSE_MEDIATED_DECAY_NMD

GSPT2 RPS4Y1 RPL7A GSPT1 RPL18A

7.96e-06116345M27921
PathwayREACTOME_TRANSLATION

GSPT2 RPS4Y1 EIF3D RPL7A GSPT1 RPL18A

1.66e-05231346MM15420
PathwayREACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS

GSPT2 RPS4Y1 RPL7A GSPT1 RPL18A

5.33e-05172345M27876
PathwayREACTOME_TRANSLATION

GSPT2 RPS4Y1 EIF3D RPL7A GSPT1 RPL18A

6.55e-05295346M8229
PathwayREACTOME_EUKARYOTIC_TRANSLATION_TERMINATION

GSPT2 GSPT1

8.42e-056342MM15419
PathwayREACTOME_SIGNALING_BY_ROBO_RECEPTORS

GSPT2 RPS4Y1 RPL7A GSPT1 RPL18A

1.63e-04218345M2780
PathwayREACTOME_EUKARYOTIC_TRANSLATION_INITIATION

RPS4Y1 EIF3D RPL7A RPL18A

1.90e-04120344M27686
PathwayREACTOME_EUKARYOTIC_TRANSLATION_INITIATION

RPS4Y1 EIF3D RPL7A RPL18A

2.09e-04123344MM15415
PathwayWP_CYTOPLASMIC_RIBOSOMAL_PROTEINS

RPS4Y1 RPL7A RPL18A

9.62e-0481343MM15911
PathwayKEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION

RPS4Y1 RPL7A RPL18A

9.62e-0481343M47786
PathwayWP_CYTOPLASMIC_RIBOSOMAL_PROTEINS

RPS4Y1 RPL7A RPL18A

1.22e-0388343M39495
PathwayKEGG_RIBOSOME

RPS4Y1 RPL7A RPL18A

1.22e-0388343M189
PathwayREACTOME_EUKARYOTIC_TRANSLATION_ELONGATION

RPS4Y1 RPL7A RPL18A

1.48e-0394343M29556
Pubmed

Evolution of a 6-200 Mb long-range repeat cluster in the genus Mus.

SP100 SP110

2.28e-06253211534816
Pubmed

Lack of reproducible growth inhibition by Schlafen1 and Schlafen2 in vitro.

SLFN12L SLFN12

2.28e-06253218479948
Pubmed

Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging.

CD9 CD81

2.28e-06253229572511
Pubmed

Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

CD9 CD81

2.28e-06253212483205
Pubmed

Infertility of CD9-deficient mouse eggs is reversed by mouse CD9, human CD9, or mouse CD81; polyadenylated mRNA injection developed for molecular analysis of sperm-egg fusion.

CD9 CD81

2.28e-06253212086470
Pubmed

CD81 interacts with the T cell receptor to suppress signaling.

CD9 CD81

2.28e-06253223226274
Pubmed

Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.

CD9 CD81

2.28e-06253223223239
Pubmed

Involvement of human release factors eRF3a and eRF3b in translation termination and regulation of the termination complex formation.

GSPT2 GSPT1

2.28e-06253215987998
Pubmed

Source and component genes of a 6-200 Mb gene cluster in the house mouse.

SP100 SP110

2.28e-06253211471051
Pubmed

CD9 and CD81 Interactions and Their Structural Modelling in Sperm Prior to Fertilization.

CD9 CD81

2.28e-06253229671763
Pubmed

Tetraspanin blockage reduces exosome-mediated HIV-1 entry.

CD9 CD81

2.28e-06253229429034
Pubmed

Functional role of Tia1/Pub1 and Sup35 prion domains: directing protein synthesis machinery to the tubulin cytoskeleton.

GSPT2 GSPT1

2.28e-06253224981173
Pubmed

Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients.

CD9 CD81

2.28e-06253236826611
Pubmed

Double deficiency of tetraspanins CD9 and CD81 alters cell motility and protease production of macrophages and causes chronic obstructive pulmonary disease-like phenotype in mice.

CD9 CD81

2.28e-06253218662991
Pubmed

Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.

CD9 CD81

2.28e-06253220124223
Pubmed

Reduced fertility of female mice lacking CD81.

CD9 CD81

2.28e-06253216380109
Pubmed

Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis.

SLFN12L SLFN12

2.28e-06253221249125
Pubmed

CD81 and CD9 work independently as extracellular components upon fusion of sperm and oocyte.

CD9 CD81

2.28e-06253223213457
Pubmed

Schlafen 12 mediates the effects of butyrate and repetitive mechanical deformation on intestinal epithelial differentiation in human Caco-2 intestinal epithelial cells.

SLFN12L SLFN12

2.28e-06253230875077
Pubmed

Impact of lactobacilli on orally acquired listeriosis.

CFLAR SLFN12L SLFN12 SP110 MX1

4.94e-0616253523012479
Pubmed

Lateral organization of membrane proteins: tetraspanins spin their web.

CD9 CD81

6.83e-06353219426143
Pubmed

Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion.

CD9 CD81

6.83e-06353217015697
Pubmed

Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1.

GSPT2 GSPT1

6.83e-0635329712840
Pubmed

Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains.

CD9 CD81

6.83e-06353217522207
Pubmed

Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases.

SLFN12L SLFN12

6.83e-06353237334372
Pubmed

CD63 is not required for production of infectious human immunodeficiency virus type 1 in human macrophages.

CD9 CD81

6.83e-06353218321974
Pubmed

The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment.

CD9 CD81

6.83e-06353214530327
Pubmed

Tetraspanins CD9 and CD81 are molecular partners of trimeric FcɛRI on human antigen-presenting cells.

CD9 CD81

6.83e-06353221241315
Pubmed

The schlafen family of proteins and their regulation by interferons.

SLFN12L SLFN12

6.83e-06353223570387
Pubmed

Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1.

SLFN12L SLFN12

6.83e-06353215946944
Pubmed

Tetraspanin CD81 is required for the alpha v beta5-integrin-dependent particle-binding step of RPE phagocytosis.

CD9 CD81

6.83e-06353217684062
Pubmed

The processed isoform of the translation termination factor eRF3 localizes to the nucleus to interact with the ARF tumor suppressor.

GSPT2 GSPT1

6.83e-06353224569073
Pubmed

Tetraspanins regulate cell-to-cell transmission of HIV-1.

CD9 CD81

6.83e-06353219602278
Pubmed

Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles.

CD9 CD81

6.83e-06353237525398
Pubmed

FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein.

CD9 CD81

6.83e-06353211087758
Pubmed

Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells.

CD9 CD81

6.83e-06353219458002
Pubmed

Gli1 deletion prevents Helicobacter-induced gastric metaplasia and expansion of myeloid cell subsets.

SLFN12L SLFN12

6.83e-06353223520544
Pubmed

Polypeptide chain release factor eRF3 is a novel molecular partner of survivin.

GSPT2 GSPT1

6.83e-06353223377885
Pubmed

Gag induces the coalescence of clustered lipid rafts and tetraspanin-enriched microdomains at HIV-1 assembly sites on the plasma membrane.

CD9 CD81

6.83e-06353221813604
Pubmed

Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages.

CD9 CD81

1.36e-05453222980332
Pubmed

The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3.

CD9 CD81

1.36e-05453227993971
Pubmed

HIV-1 assembly differentially alters dynamics and partitioning of tetraspanins and raft components.

CD9 CD81

1.36e-05453220727121
Pubmed

Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor.

CD9 CD81

1.36e-05453218981120
Pubmed

Structural insights into eRF3 and stop codon recognition by eRF1.

GSPT2 GSPT1

1.36e-05453219417105
Pubmed

The transferrin receptor and the tetraspanin web molecules CD9, CD81, and CD9P-1 are differentially sorted into exosomes after TPA treatment of K562 cells.

CD9 CD81

1.36e-05453217407154
Pubmed

Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1.

CD9 CD81

1.36e-05453216735575
Pubmed

Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance.

CD9 CD81

1.36e-05453210459022
Pubmed

Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

CD9 CD81

1.36e-05453212796480
Pubmed

HIV-1 replication in dendritic cells occurs through a tetraspanin-containing compartment enriched in AP-3.

CD9 CD81

1.36e-05453218034776
Pubmed

Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.

CD9 CD81

1.36e-05453219559406
Pubmed

CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses.

CD9 CD81

1.36e-05453223858057
Pubmed

The Hsp40 family chaperone protein DnaJB6 enhances Schlafen1 nuclear localization which is critical for promotion of cell-cycle arrest in T-cells.

SLFN12L SLFN12

1.36e-05453218373498
Pubmed

CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma.

CD9 CD81

1.36e-0545328630057
Pubmed

Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.

CD9 CD81

1.36e-05453219894777
Pubmed

An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

SLFN12L SLFN12

1.36e-05453220190759
Pubmed

Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia.

SLFN12L SLFN12

1.36e-05453227427984
Pubmed

C-kit associated with the transmembrane 4 superfamily proteins constitutes a functionally distinct subunit in human hematopoietic progenitors.

CD9 CD81

1.36e-05453212036870
Pubmed

Structural basis of ligand recognition by PABC, a highly specific peptide-binding domain found in poly(A)-binding protein and a HECT ubiquitin ligase.

GSPT2 GSPT1

2.27e-05553214685257
Pubmed

Protease nexin-1 is expressed at the mouse met-/mesencephalic junction and FGF signaling regulates its promoter activity in primary met-/mesencephalic cells.

SERPINE2 FGF8

2.27e-0555329102311
Pubmed

Schlafen-8 is essential for lymphatic endothelial cell activation in experimental autoimmune encephalomyelitis.

SLFN12L SLFN12

2.27e-05553229528433
Pubmed

CD9 controls the formation of clusters that contain tetraspanins and the integrin alpha 6 beta 1, which are involved in human and mouse gamete fusion.

CD9 CD81

2.27e-05553216418227
Pubmed

The paternal gene of the DDK syndrome maps to the Schlafen gene cluster on mouse chromosome 11.

SLFN12L SLFN12

2.27e-05553216172501
Pubmed

The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms.

CD9 CD81

2.27e-05553223613949
Pubmed

Subcellular localization of the Schlafen protein family.

SLFN12L SLFN12

2.27e-05553218355440
Pubmed

Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.

CD9 CD81

2.27e-05553217989173
Pubmed

Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration.

CD9 CD81

2.27e-05553212175627
Pubmed

Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.

SLFN12L SLFN12

2.27e-05553224089532
Pubmed

Role of Gag and lipids during HIV-1 assembly in CD4(+) T cells and macrophages.

CD9 CD81

2.27e-05553225009540
Pubmed

Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81.

CD9 CD81

2.27e-05553223575678
Pubmed

The major CD9 and CD81 molecular partner. Identification and characterization of the complexes.

CD9 CD81

3.40e-05653211278880
Pubmed

Exosomal-like vesicles are present in human blood plasma.

CD9 CD81

3.40e-05653215908444
Pubmed

The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein.

GSPT2 GSPT1

3.40e-05653210358005
Pubmed

cGMP and cyclic nucleotide-gated channels participate in mouse sperm capacitation.

CNGB3 CNGA2

3.40e-05653222192355
Pubmed

EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.

CD9 CD81

3.40e-05653211504738
Pubmed

Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

CD9 CD81

3.40e-05653216940516
Pubmed

Schlafen, a new family of growth regulatory genes that affect thymocyte development.

SLFN12L SLFN12

3.40e-0565329846487
Pubmed

Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.

SP100 MX1

3.40e-05653211716541
Pubmed

CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82.

CD9 CD81

3.40e-0565329804823
Pubmed

Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.

CD9 CD81

4.76e-05753215284116
Pubmed

NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins.

CD9 CD81

4.76e-0575329360996
Pubmed

Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization.

CD9 CD81

4.76e-05753223395392
Pubmed

TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization.

CD9 CD81

6.34e-05853226686862
Pubmed

CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans.

CD9 CD81

6.34e-05853210741407
Pubmed

Evolution of the Schlafen genes, a gene family associated with embryonic lethality, meiotic drive, immune processes and orthopoxvirus virulence.

SLFN12L SLFN12

6.34e-05853219619625
Pubmed

Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencing.

GSPT2 GSPT1

8.15e-05953221726813
Pubmed

TspanC8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals.

CD9 CD81

1.02e-041053223091066
Pubmed

International Union of Pharmacology. LI. Nomenclature and structure-function relationships of cyclic nucleotide-regulated channels.

CNGB3 CNGA2

1.02e-041053216382102
Pubmed

HIV-1 Assembly at the Plasma Membrane: Gag Trafficking and Localization.

CD9 CD81

1.24e-041153219802344
Pubmed

ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.

CD9 CD81

1.24e-041153216054021
Pubmed

Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions.

CD9 CD81

1.49e-041253210229664
Pubmed

A map of 75 human ribosomal protein genes.

RPS4Y1 RPL7A RPL18A

1.49e-04675339582194
Pubmed

Sox2+ stem cells contribute to all epithelial lineages of the tooth via Sfrp5+ progenitors.

CD9 FGF8

1.76e-041353222819339
Pubmed

Mapping of the genes for four members of the transmembrane 4 superfamily: mouse Cd9, Cd63, Cd81, and Cd82.

CD9 CD81

2.05e-04145327590978
Pubmed

Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay.

GSPT2 GSPT1

2.05e-041453216452507
Pubmed

Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.

TRIM66 SP100 SP110

2.09e-047553325593309
Pubmed

Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.

MYCBP2 DHX40 DYNLT1 EIF3D RPL7A SORCS1 RPL18A

2.18e-0480953732129710
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

TGM4 SLFN12L TCAF1 CEP162 SLFN12 PRAMEF13 KLHL32 MADD

2.22e-04108453811544199
Pubmed

Cdh1-APC Regulates Protein Synthesis and Stress Granules in Neurons through an FMRP-Dependent Mechanism.

RPS4Y1 EIF3D RPL7A RPL18A

2.35e-0419753432434143
Pubmed

Structure and evolution of mammalian ribosomal proteins.

RPS4Y1 RPL7A RPL18A

2.53e-04805338722009
Pubmed

Structure of the human 80S ribosome.

RPS4Y1 RPL7A RPL18A

2.72e-048253325901680
GeneFamilySchlafen family

SLFN12L SLFN12

6.75e-0573321110
GeneFamilyCyclic nucleotide gated channels

CNGB3 CNGA2

1.44e-0410332250
GeneFamilyPHD finger proteins

TRIM66 SP100 SP110

5.84e-049033388
GeneFamilyCD molecules|Tetraspanins

CD9 CD81

1.65e-0333332768
GeneFamilyEndogenous ligands|Minor histocompatibility antigens

RPS4Y1 SP110

3.90e-0351332870
GeneFamilyL ribosomal proteins

RPL7A RPL18A

3.90e-0351332729
GeneFamilyRing finger proteins|Tripartite motif containing|ARF GTPase family

TRIM66 TRIM36

1.30e-029533259
CoexpressionGSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP

SERPINE2 ZNF532 NXPE4 SLCO1A2 SP110 SORD

2.94e-06198536M4451
CoexpressionGSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN

SP100 MYCBP2 SLFN12 DYNLT1 SP110 MX1

3.12e-06200536M8967
CoexpressionSTAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN

SP100 CD9 SP110 MX1

3.47e-0651534M2102
CoexpressionHELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS

SERPINE2 SLCO1A2 ACSF2 MX1

1.81e-0577534M19128
CoexpressionEINAV_INTERFERON_SIGNATURE_IN_CANCER

SP100 SP110 MX1

2.21e-0527533M5091
CoexpressionGSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN

SP100 SLFN12 LMBRD2 SP110 MX1

5.00e-05198535M3296
CoexpressionGSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN

SP100 SLFN12 DYNLT1 SP110 MX1

5.12e-05199535M8971
CoexpressionGSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN

CFLAR SP100 DYNLT1 SP110 MX1

5.24e-05200535M3279
CoexpressionGSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP

CFLAR SLFN12L MYCBP2 SLFN12 S1PR2

5.24e-05200535M6625
CoexpressionONO_AML1_TARGETS_DN

SLFN12L SLFN12 CD81

9.75e-0544533MM1269
CoexpressionMATZUK_FERTILIZATION

CD9 CD81

1.11e-048532M1811
CoexpressionGRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP

SLFN12L SP100 SLFN12 SP110 MX1

1.12e-04235535MM978
CoexpressionLAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES

DPYD SP100

1.79e-0410532M39249
CoexpressionJOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP

SERPINE2 CD9 DYNLT1

2.11e-0457533M1120
CoexpressionGREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB

SP100 S1PR2 RO60 SP110

2.13e-04145534M2137
CoexpressionJOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP

SERPINE2 CD9 DYNLT1

2.46e-0460533MM1101
CoexpressionRATTENBACHER_BOUND_BY_CELF1

TGM4 SP100 TCAF1 CFAP54 SERPINE2 CD9

2.67e-04444536M2505
CoexpressionBROWNE_INTERFERON_RESPONSIVE_GENES

SP100 SP110 MX1

3.41e-0467533M9221
CoexpressionLEIN_NEURON_MARKERS

TCAF1 UNC80 MADD

3.72e-0469533M1712
CoexpressionLEIN_NEURON_MARKERS

TCAF1 UNC80 MADD

3.88e-0470533MM714
CoexpressionGSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN

SERPINE2 CD9 MYCBP2 CD81

3.90e-04170534M8188
CoexpressionRUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS

CD9 RPS4Y1 EIF3D RPL7A RPL18A

4.04e-04310535M41748
CoexpressionBILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES

RPS4Y1 RPL7A RPL18A

4.39e-0473533MM1304
CoexpressionRUBENSTEIN_SKELETAL_MUSCLE_T_CELLS

RPS4Y1 EIF3D RPL7A RPL18A

4.95e-04181534M41752
CoexpressionTABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING

SERPINE2 MYCBP2 RPS4Y1 RPL7A RPL18A

5.15e-04327535MM3714
CoexpressionRUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP

CFLAR UFSP2 CD9 CD81 RO60

6.23e-04341535M12636
CoexpressionGSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN

SP100 SLFN12 DYNLT1 SP110

6.42e-04194534M6082
CoexpressionJOHNSTONE_PARVB_TARGETS_2_DN

DPYD TCAF1 ZNF532 MYCBP2 RO60

6.48e-04344535M2239
CoexpressionGAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP

TCAF1 DTNA SLCO1A2 SORD

6.54e-04195534M1110
CoexpressionGSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN

SP100 DYNLT1 SP110 MX1

6.54e-04195534M4292
CoexpressionGSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN

CFLAR SP100 SP110 MX1

6.67e-04196534M9590
CoexpressionGSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN

CFLAR SP100 DYNLT1 MX1

6.80e-04197534M3344
CoexpressionGSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN

CFLAR DYNLT1 SP110 MX1

6.80e-04197534M3338
CoexpressionGSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN

SP100 L2HGDH SP110 MX1

6.80e-04197534M9580
CoexpressionGSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN

SP100 DYNLT1 SP110 MX1

6.80e-04197534M4294
CoexpressionGSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN

SP100 DYNLT1 SP110 MX1

6.80e-04197534M6835
CoexpressionGSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP

DPYD EIF3D SP110 SORD

6.80e-04197534M3144
CoexpressionGSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN

SP100 SLFN12 SP110 MX1

6.93e-04198534M8969
CoexpressionGSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN

SP100 DYNLT1 SP110 MX1

6.93e-04198534M4264
CoexpressionGSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP

GSPT2 CD81 SP110 SORD

6.93e-04198534M9803
CoexpressionGSE23695_CD57_POS_VS_NEG_NK_CELL_UP

MYCBP2 CD81 DYNLT1 MADD

7.06e-04199534M7784
CoexpressionGSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN

SP100 DYNLT1 SP110 MX1

7.06e-04199534M4635
CoexpressionGSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN

CFLAR SP100 SP110 MX1

7.06e-04199534M7667
CoexpressionGSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP

SP100 RPS4Y1 SP110 MX1

7.06e-04199534M7656
CoexpressionGSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP

SP100 WDR7 SP110 MX1

7.06e-04199534M7652
CoexpressionGSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP

SP100 DYNLT1 SP110 MX1

7.06e-04199534M5359
CoexpressionGSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN

CFLAR DYNLT1 SP110 MX1

7.06e-04199534M5242
CoexpressionGSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP

SERPINE2 DHX40 DYNLT1 PRIMPOL

7.06e-04199534M8636
CoexpressionGSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN

SP100 DYNLT1 SP110 MX1

7.06e-04199534M6837
CoexpressionGSE22886_NAIVE_TCELL_VS_DC_UP

SP100 MYCBP2 SP110 RPL7A

7.06e-04199534M4475
CoexpressionGSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN

SERPINE2 CD9 RO60 RPL7A

7.19e-04200534M5135
CoexpressionGSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP

CFLAR SLFN12L SERPINE2 MYCBP2

7.19e-04200534M9360
CoexpressionGSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN

SP100 MYCBP2 SP110 MX1

7.19e-04200534M7618
CoexpressionGSE17721_LPS_VS_CPG_16H_BMDC_UP

CFLAR SLFN12L SERPINE2 DYNLT1

7.19e-04200534M4007
CoexpressionGSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN

CFLAR DYNLT1 SP110 MX1

7.19e-04200534M9539
CoexpressionGSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN

CFLAR DYNLT1 SP110 MX1

7.19e-04200534M9533
CoexpressionGSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN

DPYD SP100 SP110 MX1

7.19e-04200534M9588
CoexpressionGSE1460_DP_VS_CD4_THYMOCYTE_DN

SP100 SLCO1A2 SLFN12 SP110

7.19e-04200534M3454
CoexpressionGSE10325_BCELL_VS_LUPUS_BCELL_DN

CFLAR SLFN12 DYNLT1 MX1

7.19e-04200534M3095
CoexpressionBROWN_MYELOID_CELL_DEVELOPMENT_UP

SLFN12L SP100 NXPE4 SLFN12

7.33e-04201534MM1006
CoexpressionTABULA_MURIS_SENIS_BRAIN_MYELOID_MICROGLIAL_CELL_AGEING

CD9 RPS4Y1 CD81 RPL7A RPL18A

7.56e-04356535MM3684
CoexpressionAtlaskidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000

CFLAR SLFN12L SP100 CD9 SLFN12 FGD5 SP110 MX1

5.71e-07302518gudmap_kidney_adult_CortVasc_Tie2_k2_1000
CoexpressionAtlaskidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000

CFLAR SLFN12L SP100 SERPINE2 CD9 SLFN12 FGD5 SP110 MX1 SORD

2.77e-058465110gudmap_kidney_adult_CortVasc_Tie2_1000
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000

CFLAR SLFN12L SP100 SERPINE2 CD9 SLCO1A2 SLFN12 CD81 FGD5 SP110

2.88e-058505110gudmap_kidney_adult_RenMedVasc_Tie2_1000
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_500

SLFN12L SP100 CD9 FGD5 SP110

5.26e-05169515gudmap_kidney_adult_RenMedVasc_Tie2_k2_500
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_500

SLFN12L SP100 CD9 SLCO1A2 SLFN12 FGD5 SP110

5.89e-05417517gudmap_kidney_adult_RenMedVasc_Tie2_500
CoexpressionAtlaskidney_adult_RenMedVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000

CFLAR SLFN12L SP100 CD9 FGD5 SP110

9.90e-05312516gudmap_kidney_adult_RenMedVasc_Tie2_k2_1000
CoexpressionAtlaskidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000

CFLAR SLFN12L SP100 CD9 SLFN12 CD81 FGD5 SP110 MX1

1.73e-04852519gudmap_kidney_adult_GlomCapSys_Tie2_1000
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SP100 SLFN12 DYNLT1 SP110 MX1

2.07e-0617553597616bb5c127284aa9e67bc336dfcf29e137164b
ToppCellT_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

SLFN12L SP100 DYNLT1 SP110 MX1

2.95e-061885356f8946d4710f6e32c937213f99b790b098b8819c
ToppCellcritical-Epithelial-IRC-IFNG_responsive_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD9 DYNLT1 RPL7A MX1 RPL18A

3.43e-06194535568e1676a61063a5d858a43b86f8c2ad536505c2
ToppCellBAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SLFN12L SERPINE2 RPS4Y1 RPL7A RPL18A

3.61e-0619653564b23d819efddb25024c86f2e1b5dc4159337ddd
ToppCellILEUM-non-inflamed-(1)_T_cell-(1)_Naive_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SERPINE2 RPS4Y1 EIF3D RPL7A RPL18A

3.61e-06196535eda187f50e1bcf8f9bc9af3ea05c63748d66570a
ToppCellBAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SLFN12L SERPINE2 RPS4Y1 RPL7A RPL18A

3.61e-06196535ba46f80d1497eaf4d71b59504106ba4b84e4ff9f
ToppCellBAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SLFN12L SERPINE2 RPS4Y1 RPL7A RPL18A

3.61e-06196535eb0b711ca6da7b5e5313791c3c3985358e2a222e
ToppCellMild-CD8+_T_activated|World / Disease group and Cell class

SLFN12L SP100 DYNLT1 SP110 MX1

3.61e-0619653579632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCellMild-CD4+_T_activated|World / Disease group and Cell class

SLFN12L SP100 DYNLT1 SP110 MX1

3.61e-06196535417b4fc2e4388f34c410576131b02936f93e46b6
ToppCellNS-critical-d_16-33-Epithelial-IRC-IFNG_responsive_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD9 RPS4Y1 RPL7A SORD RPL18A

3.70e-061975358eb007fe2a60b1bfc9d0fd5fc92d2f21388806f7
ToppCellVE|World / Condition, Cell_class and T cell subcluster

SP100 MYCBP2 CD81 SP110 MX1

3.98e-062005358ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF532 NXPE4 KLHL32 MX1

3.66e-05157534ec433d2fe827abdb647be4176c231b7052482b6f
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF532 NXPE4 KLHL32 MX1

4.23e-051635348dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZNF532 NXPE4 KLHL32 MX1

4.23e-05163534fd243ca223079033be480a24817a399f281fa4d4
ToppCellCerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32

SP100 NXPE4 SLFN12 FGD5

4.44e-051655347d319a112b9062efee428bef6f4534d2ce782e04
ToppCelldroplet-Marrow-nan-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 ZFAT NXPE4 SLFN12

4.87e-051695345f5bec13208f4c3b6eacbba180c8a6402743b76e
ToppCellControl-Epithelial_alveolar-AT_1-AT1_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CD9 RPS4Y1 CD81 RPL7A

4.99e-05170534bfce0984b41e0c532e7ba264972593a382f0637c
ToppCellIIF-Lymphocyte-T_NK-CD4_TEM|IIF / Disease, Lineage and Cell Type

RPS4Y1 SLCO1A2 RPL7A RPL18A

5.58e-051755340e7cde3bd638ab85abe915d40c432123f92af4fc
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

ZFAT ZNF532 RPS4Y1 CD81

5.58e-0517553469ed3c7c45df6bef70f5f2ff003531160bf3b32b
ToppCelldroplet-Lung-LUNG-30m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP100 CD81 CACNA1I RPL18A

6.36e-0518153446de8c18e4ec8dc9d07f7c8cc7b5f48b9c613aae
ToppCellCalu_3-infected|Calu_3 / Cell line, Condition and Strain

CFLAR SP100 SP110 MX1

6.64e-051835348f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLFN12 ACSF2 TRIM36 SORD

6.64e-05183534919c9861073d12fd12aecd7469b1478b13838c43
ToppCellCOVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type

ZFAT ACSF2 SORD SORCS1

6.78e-05184534dc71f22583fc54b89b242cbb602f4bbe86f576ec
ToppCellCOVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type

SERPINE2 ZFAT ACSF2 SORCS1

7.22e-05187534acd305475f3609800af0d7bc68d83ef41228080b
ToppCelldroplet-Large_Intestine-COLON:P+D-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD9 NXPE4 CD81 SORD

7.37e-05188534bfd3b4f57785596b2bd2c657e0d2d8b0f40ba36d
ToppCellNS-critical-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNLT1 RPL7A MX1 RPL18A

7.37e-051885346ee2e7fa80f48e4a7f3321b0776a4f697469bc61
ToppCellNon-neuronal-Postmitotic-Red_blood_cells-Low_Quality|World / Primary Cells by Cluster

RPS4Y1 DYNLT1 RPL7A RPL18A

7.68e-0519053431cf1367db5c04242621f7c98a10d094bc519e31
ToppCellNon-neuronal-Postmitotic-Red_blood_cells|World / Primary Cells by Cluster

RPS4Y1 DYNLT1 RPL7A RPL18A

7.68e-05190534f0b82334375749d917e440c493f10340c52ea13c
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SP100 MYCBP2 SP110 RPL18A

7.68e-05190534a7498fe55b7810c482291db782dc5282675d246a
ToppCellNon-neuronal-Postmitotic-Red_blood_cells-Low_Quality-14|World / Primary Cells by Cluster

RPS4Y1 DYNLT1 RPL7A RPL18A

7.68e-05190534feadd834d843f952aa7ced93899fd1f0868743df
ToppCellPCW_13-14|World / Celltypes from embryonic and fetal-stage human lung

SLFN12L SP100 RPS4Y1 CD81

7.68e-0519053462a3ec1ae0829602b0569cc051210551644f1d46
ToppCellCV-Mild-5|CV / Virus stimulation, Condition and Cluster

SERPINE2 CD9 MX1 RPL18A

7.83e-05191534cf40d2b3daeb968b05b4dc2a0a9dc3eb9a0cccfa
ToppCell368C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

CD9 CD81 FGD5 MX1

7.99e-05192534e1deb743b1f39b58a46b8df134e79d512a000273
ToppCellEntopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32

TRIM66 MYCBP2 CACNA1I UNC80

7.99e-051925344c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD9 CD81 RPL7A RPL18A

7.99e-05192534033e5e61930c28e28a7c64794858f6526e30ff74
ToppCellCOVID-19_Mild|World / Disease condition and Cell class

SP100 DYNLT1 SP110 MX1

8.15e-051935347256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCellMild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

SP100 MYCBP2 SP110 MX1

8.32e-0519453401c97543972159a9468272da06e7e611e2c21fae
ToppCellCOVID-19-Myeloid-TRAM2|COVID-19 / Condition, Lineage and Cell class

CD9 DTNA CD81 FGD5

8.32e-05194534c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f
ToppCellHSPCs-Mk_prog.|HSPCs / Lineage and Cell class

SERPINE2 CD9 CD81 MADD

8.32e-051945345c05d508f5c29e6efe87506bf59e3b0fe5922f65
ToppCellNS-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MYCBP2 CD81 RPL7A RPL18A

8.49e-051955341c0d8dbe8490c35903061469e395b218416b1aa2
ToppCellfacs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDR7 KLHL32 UNC80 MADD

8.49e-05195534bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCellCOVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class

SLFN12L SP100 CD81 MX1

8.49e-05195534070c5d3bdbd4ea54a579c01c37fb99bcf823982e
ToppCellB_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis

SLFN12L DYNLT1 SP110 MX1

8.49e-05195534b64d9e1a8834401b4dc501566546647754ae21fc
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

SP100 CD81 MX1 SORCS1

8.49e-05195534633c7668fe365f7b0f7851cdc442d5dd89c454e2
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYCBP2 KLHL32 UNC80 MADD

8.49e-051955343e519cffa6144a62b06124642a14c9ff39b76554
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYCBP2 KLHL32 UNC80 MADD

8.49e-051955347796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellASK440-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq

CD9 EIF3D RPL7A RPL18A

8.65e-05196534833723c8753922374cd7730907f1596899dd5734
ToppCellmild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SP100 DYNLT1 SP110 MX1

8.65e-05196534ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCellMild-CD4+_T_activated|Mild / Disease group and Cell class

SP100 DYNLT1 SP110 MX1

8.65e-05196534daa1c3322d81e649161e889e1d78451d2d425d09
ToppCellMild|World / Disease group and Cell class

SLFN12L DYNLT1 SP110 MX1

8.65e-051965345e4ed4a5a437cfa002b92775992a791e27aa4c27
ToppCell3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SERPINE2 CD9 DTNA SORCS1

8.83e-05197534bb35a2b7320fda92e9cd42f536b7bd54e3a73a32
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SP100 MYCBP2 SP110 RPL18A

8.83e-0519753443e576bd6997915d21137e233e36984eba31f637
ToppCellPCW_10-12|World / Celltypes from embryonic and fetal-stage human lung

DPYD SP100 RPS4Y1 CD81

8.83e-0519753447fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCellCOVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class

SLFN12L SP100 CD81 MX1

8.83e-051975344711ecb157e907758a5021248ae8b043d17672c6
ToppCellcontrol-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CFLAR SP100 SP110 MX1

8.83e-051975348819db1550bf14566c6d33d97f7f83419e867ace
ToppCellMild-Lymphoid-T-CCR7+_T|Mild / Condition, Lineage, Cell class and cell subclass

SLFN12L SP100 RPL7A RPL18A

8.83e-05197534f23bd8f6ad011730699a5bb7211cd0feeaebc42b
ToppCellNS-critical-d_16-33-Lymphoid|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

MYCBP2 CD81 RPL7A RPL18A

8.83e-05197534c6c33f8e2cfd4c6853e77bc3ad334ae41069758c
ToppCellCOVID-19_Severe-NK_activated|World / disease group, cell group and cell class

SLFN12L SP100 RPS4Y1 MX1

8.83e-05197534a60db36d1a192998e3ded63e0c7c08d41689f95f
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SLFN12L CD81 RPL7A RPL18A

8.83e-05197534fef3ccfadc06d11244b71395b0a13280841dd368
ToppCell11.5-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class

SERPINE2 RPS4Y1 RPL7A RPL18A

9.00e-05198534fe08709d043d927988b1bb262c766b0b572fc927
ToppCellCV-Severe-1|Severe / Virus stimulation, Condition and Cluster

SP100 RPS4Y1 SP110 MX1

9.00e-051985349b9ee0b0f6cc92e7be94869604c98f43d57ff8ff
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CD9 RPS4Y1 CD81 DYNLT1

9.00e-0519853490b831e36213bfd653b2bfa40f0bb581129d2530
ToppCellmild|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLFN12L CD81 RPL7A RPL18A

9.00e-051985343cef2e13d5ec71bb265171239980697a2560fa30
ToppCellCV-Severe-1|CV / Virus stimulation, Condition and Cluster

SP100 RPS4Y1 SP110 MX1

9.00e-05198534fc0e885e370ffb780eada62bb2b52065c2f8b26b
ToppCell10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

RPS4Y1 CD81 RPL7A RPL18A

9.00e-05198534aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCellsevere-Lymphocytic|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLFN12L CD81 RPL7A RPL18A

9.00e-051985347b85f763a5f5fb7bed8e0d702364a2dd18a74f7d
ToppCellNS-moderate-d_16-33-Epithelial-Basal|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DYNLT1 RPL7A SORD RPL18A

9.00e-051985345c52b69d65909b667ef0943e7e04572c9d5b1ba0
ToppCellCV|World / Virus stimulation, Condition and Cluster

DPYD SP100 SP110 MX1

9.00e-051985346a28193af35abec5c029129930c2ca6febaafde2
ToppCellCD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

DPYD SP100 SP110 MX1

9.00e-051985343d1749f5106f0912f4a74615863853949f52c73d
ToppCellMild-CD8+_T_activated|Mild / Disease group and Cell class

SP100 DYNLT1 SP110 MX1

9.00e-05198534ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCellsevere-Lymphocytic-CD8_T_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLFN12L CD81 RPL7A RPL18A

9.00e-051985342cd13418396ab2c53b1be96e7795841c2482bfca
ToppCellCV-Mild-1|CV / Virus stimulation, Condition and Cluster

SP100 DYNLT1 SP110 MX1

9.00e-051985344b078714c49e7befb7b113d72485e712236d35fa
ToppCellBAL-Severe|BAL / Compartment, Disease Groups and Clusters

CFLAR DYNLT1 SP110 MX1

9.00e-05198534f63cfcc57f46094ea0673bbc70ea443ebaca6176
ToppCellBAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters

SP100 DYNLT1 SP110 MX1

9.18e-05199534c55181bdec8952b54198f0d4c9c5c84265b16572
ToppCell11.5|World / Age, Tissue, Lineage and Cell class

RPS4Y1 CD81 RPL7A RPL18A

9.18e-05199534e93807954c504745e295edc39883e1ed21f4cd93
ToppCellVE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster

SP100 DYNLT1 SP110 MX1

9.18e-05199534056a0538ca5e825ae6195b4c76c208708a014533
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster

DPYD RPS4Y1 RPL7A SORCS1

9.18e-051995341b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCellmild-Lymphocytic|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SLFN12L CD81 RPL7A RPL18A

9.18e-0519953457a429b4c98decbd0bffb67733eaae1f907898a3
ToppCellmild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SLFN12L SP100 CD81 MX1

9.18e-05199534cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Dendritic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD9 CD81 RPL7A RPL18A

9.18e-051995342d57afe29276995c500b74da4771b2572bc80587
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

SLFN12L SP100 SP110 MX1

9.18e-05199534952fac67588ad5676f5939e3c7f8bac803c27064
ToppCellNS-critical-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD9 RPL7A SORD RPL18A

9.18e-05199534581cbc077d7fa25015e80de561b5ff161a0393df
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster

DPYD RPS4Y1 RPL7A SORCS1

9.18e-051995344bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCellCOVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class

SLFN12L SP100 RPS4Y1 MX1

9.18e-05199534a16b961996291bd5958c3851b7fdd7b45c53e19b
ToppCell(2)_B_cell-(23)_Follicular_B_cell|(2)_B_cell / shred on Cell_type and subtype

SP100 SP110 RPL7A RPL18A

9.18e-05199534da661933bfa43ad7069a4bc75aef6a72ccd5796e
ToppCell5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SERPINE2 CD9 DTNA SORCS1

9.18e-05199534a816b0eed80530113b7e720bbd2311a544ed8ed1
ToppCellCOVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations)

SERPINE2 CD81 RPL7A RPL18A

9.36e-0520053473e01b7bc43320a991c67a4fd0c04708f893c7ea
ToppCellmild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SLFN12L SP100 CD81 MX1

9.36e-05200534d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCellcritical-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

RPS4Y1 CD81 RPL7A RPL18A

9.36e-05200534e2d0e635b70f4bc25e1d374d46e63efbb2e2be0f
ToppCellPBMC-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SLFN12L CD81 RPL7A RPL18A

9.36e-0520053473b91cb66c375b44e852404a4a445cf2b9595aee
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type.

RPS4Y1 EIF3D RPL7A RPL18A

9.36e-05200534ea1e3eeddbc398ac97863120f7aa3f17569ca12a
ToppCellNS-critical-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD9 RPL7A SORD RPL18A

9.36e-052005346a76c8e3d937a9c54eb81cab23b8a898f9600de1
ToppCellsystemic_lupus_erythematosus|World / PBMC cell types (v2) per disease, treatment status, and sex

RPS4Y1 DYNLT1 SP110 MX1

9.36e-05200534d5beabeb3545750e14620064a92c72eff9d9572d
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type.

RPS4Y1 EIF3D RPL7A RPL18A

9.36e-052005344a57f2f2dc6e2402ac4772b5cd38e033a6f1adee
ToppCellNS-critical-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD9 RPL7A SORD RPL18A

9.36e-05200534047e00f31ca744f82d61cac0e4e66563381f214b
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK|COVID-19_Severe / Disease, condition lineage and cell class

SLFN12L CD81 RPL7A RPL18A

9.36e-05200534323cb89add511fbe9896b4df0f1f2b7fdbb6c649
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SP100 MYCBP2 SP110 MX1

9.36e-0520053412f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellmild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SLFN12L SP100 CD81 MX1

9.36e-05200534109f673a4967ffa52270a0b4f818b3461288db44
ToppCellcritical-Epithelial-Secretory-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

CD9 RPL7A SORD RPL18A

9.36e-05200534407465404c5818bd2cd9d489bfbf29c3a55429d4
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type.

DPYD SERPINE2 DYNLT1 TRIM36

9.36e-0520053419055194a5e0ea122f1b8fc62df44813f6843c95
ComputationalGenes in the cancer module 32.

RPS4Y1 RO60 EIF3D RPL7A GSPT1 RPL18A

4.51e-05241306MODULE_32
ComputationalViral anti-apoptotic evasion mechanisms.

CFLAR MX1 GSPT1

2.93e-0447303MODULE_312
DrugCarbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A

CFLAR DTNA RPS4Y1 CEP162 SLCO1A2 SP110

6.55e-061985366786_UP
DrugN-hydroxymethylformamide

MX1 SORD

1.59e-053532CID000083086
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

SERPINE2 CEP162 CACNA1I ACSF2 TRIM36

5.85e-051785356454_UP
DrugPropofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A

CFLAR SP100 DTNA CEP162 SP110

6.16e-051805355306_UP
Drugradicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

CFLAR DTNA RO60 TRIM36 SP110

7.39e-05187535953_UP
Drugtrifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A

CFLAR DPYD DTNA CEP162 CACNA1I

7.39e-051875356984_UP
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

TRIM66 CEP162 RO60 SP110 MADD

7.57e-051885351667_UP
DrugRapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A

CFLAR SP100 DTNA CEP162 SP110

7.77e-051895351646_UP
DrugT3-A

CFLAR SERPINE2 MX1

8.05e-0536533CID000121591
DrugConvolamine hydrochloride [500-56-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A

CFLAR DTNA CACNA1I TRIM36 GSPT1

8.16e-051915352771_UP
DrugFenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A

CFLAR DTNA TRIM36 MADD GSPT1

8.36e-051925354743_DN
DrugSolanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A

CFLAR DTNA L2HGDH CD81 GSPT1

9.00e-051955352808_DN
DrugCisapride [81098-60-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A

CFLAR SP100 WDR7 DTNA RO60

9.00e-051955355305_DN
DrugVinpocetine [42971-09-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A

CFLAR SP100 SERPINE2 RPS4Y1 CACNA1I

9.22e-051965357213_UP
DrugMethoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A

TRIM66 SP100 UFSP2 DTNA SP110

9.22e-051965355007_DN
DrugMefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A

DTNA RPS4Y1 RO60 SP110 MX1

9.22e-051965355109_UP
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A

CFLAR SP100 DTNA CEP162 SP110

9.44e-051975352848_DN
DrugMemantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A

CFLAR SP100 DTNA CACNA1I RO60

9.44e-051975354135_DN
DrugBetulin [473-98-3]; Up 200; 9uM; MCF7; HT_HG-U133A

SP100 RPS4Y1 CEP162 CNGB3 ACSF2

9.44e-051975357454_UP
DrugDicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A

CFLAR DTNA RPS4Y1 CNGB3 MX1

9.44e-051975353307_UP
DrugSB 203580; Up 200; 1uM; MCF7; HT_HG-U133A

DTNA CEP162 RO60 ACSF2 GSPT1

9.44e-051975357061_UP
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A

CFLAR TRIM66 SP100 DTNA CNGB3

9.67e-051985351506_DN
DrugMesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

CFLAR SP100 SERPINE2 CNGB3 SP110

9.67e-051985352874_UP
DrugIopamidol [60166-93-0]; Up 200; 5.2uM; PC3; HT_HG-U133A

CFLAR CNGB3 RO60 SP110 MX1

9.67e-051985355832_UP
DrugIsoxicam [34552-84-6]; Down 200; 12uM; HL60; HT_HG-U133A

CFLAR TRIM66 SERPINE2 SP110 MX1

9.67e-051985351862_DN
DrugDiprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A

CFLAR SP100 DTNA CNGB3 RO60

9.67e-051985351689_UP
DrugHexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A

CFLAR DTNA RO60 SP110 MADD

9.90e-051995356244_DN
Drugrapamycin, Streptomyces hygroscepicus; Up 200; 0.1uM; MCF7; HT_HG-U133A

SERPINE2 GSPT2 DTNA CEP162 RO60

9.90e-051995355927_UP
DrugCarbarsone [121-59-5]; Up 200; 15.4uM; HL60; HT_HG-U133A

SP100 SERPINE2 DTNA RO60 SP110

9.90e-051995351313_UP
DrugAlfadolone acetate [23930-37-2]; Down 200; 10.2uM; PC3; HT_HG-U133A

CFLAR TRIM66 SP100 ACSF2 MADD

9.90e-051995357262_DN
DrugD04031

CFLAR CD9 MX1

1.28e-0442533CID011954380
Diseaseresponse to triptolide, cytotoxicity measurement

CFLAR ZNF532

3.33e-0416502EFO_0006952, EFO_0007662
Diseaselysophosphatidylethanolamine 20:4 measurement

SLCO1A2 CACNA1I

1.11e-0329502EFO_0010370
Diseasemean arterial pressure

WDR7 L2HGDH S1PR2 FGD5 TRIM36

1.54e-03499505EFO_0006340
DiseaseBorderline personality disorder

DPYD CCDC168

1.62e-0335502HP_0012076
Diseaselifestyle measurement, anxiety disorder measurement

CFAP54 ACSF2 SORCS1

1.64e-03137503EFO_0007795, EFO_0010724
DiseaseMalignant neoplasm of breast

DPYD SERPINE2 ZNF532 FGD5 SP110 CNGA2 SORCS1

2.11e-031074507C0006142
Diseasecognitive function measurement

DPYD HEATR4 CNGB3 FGF8 CACNA1I LMBRD2 TRIM36 KLHL32

2.65e-031434508EFO_0008354

Protein segments in the cluster

PeptideGeneStartEntry
LKVGDSLCQMKEYKL

CFAP54

131

Q96N23
ELMKDLGVKIICGKS

DPYD

246

Q12882
MELEYVLKKVGCKAL

ACSF2

161

Q96CM8
ETFKKGLGLKIMLKC

SORD

336

Q00796
MGVEGCTKCIKYLLF

CD81

1

P60033
EERYKMKSKPLGICL

CFLAR

241

O15519
LAKCYGGDITRKMKL

GUF1

621

Q8N442
KVYKGMLDLLKCTVL

MADD

1006

Q8WXG6
DIKKKEPYCRGLMAI

L2HGDH

171

Q9H9P8
VDKYKDMGTVVLGKL

GSPT2

436

Q8IYD1
PLKYLKDRMAKVCDG

FGD5

1281

Q6ZNL6
MRYGVNGVGKILKKI

SERPINE2

81

P07093
IVDKYKDMGTVVLGK

GSPT1

306

P15170
ETGLYICMNKKGKLI

FGF8

121

P55075
MPVKGGTKCIKYLLF

CD9

1

P21926
MVYLGIKGKDLCLFC

IL36B

61

Q9NZH7
VLKMVALGIFGKKCY

CACNA1I

131

Q9P0X4
DICMKLEEGKYLILK

EIF3D

496

O15371
KLGKPFKYIVTCVIM

DYNLT1

56

P63172
GMILNYSKLKGKEEC

HEATR4

26

Q86WZ0
SLGYCGENKEKKLLM

CEP162

601

Q5TB80
LATLCGGKIMDKLRY

DTNA

136

Q9Y4J8
MGLKCITLKGKKSLF

CCDC168

3806

Q8NDH2
IKYMTDGCLLKHILG

DHX40

146

Q8IX18
KVKLYGSDKSCRMLL

S1PR2

136

O95136
DGKKMVALLIEYVCK

PRIMPOL

126

Q96LW4
CYLKEMKTLGKLVFS

PRAMEF13

226

Q5VWM6
GYIMELIAKGKVTIK

TRIM36

11

Q9NQ86
EKLVKFMKCGGGLLI

TCAF1

136

Q9Y4C2
ILKKCPTEYQEKMGR

LMBRD2

271

Q68DH5
KMKECLRGKLIYLMG

NXPE4

336

Q6UWF7
KMGVPYCIIKGKARL

RPL7A

176

P62424
YKLCKVRKITVGVKG

RPS4Y1

121

P22090
KIIKMEGKIVVYTAC

MYCBP2

631

O75592
ELQLYTGKKMAKLCD

TGM4

511

P49221
ICIGYIIGGLIMKKF

SLCO1A2

366

P46721
VTCGEAKGILYKKKM

SP110

466

Q9HB58
LKKMKKSSGEIVYCG

RPL18A

51

Q02543
YRKKMDIPAKLIVCG

RO60

486

P10155
ICRKGDIGKEMYIIK

CNGA2

481

Q16280
VCKKGEIGKEMYIIK

CNGB3

551

Q9NQW8
EKCILKYMKGTSIVV

UFSP2

181

Q9NUQ7
IKIGEPKIIYKCSMC

ZNF532

896

Q9HCE3
LKGLIGKRAMKCPYC

ZFAT

871

Q9P243
TMLIKIVKSLGCAYG

UNC80

791

Q8N2C7
AKIGGYTKKVCVMTK

SLFN12L

501

Q6IEE8
KLSIRCGGYTLKVLM

SP100

656

P23497
LAKIGGYTKKVCVMT

SLFN12

481

Q8IYM2
QGEACIMGAKRIYKK

SORCS1

686

Q8WY21
GLSMYDQKKCEKLVL

TRIM66

1041

O15016
IIMYCLEGSLVKKKG

WDR7

1331

Q9Y4E6
LYIIGGKKREVCKVK

KLHL32

291

Q96NJ5
LKKGYMIVKCRGQQE

MX1

271

P20591